Navigation Links
FDA Approves ULORIC(R) (febuxostat) for the Chronic Management of Hyperuricemia in Patients with Gout
Date:2/13/2009

First new treatment option in more than 40 years, marking second FDA approval for Takeda within one month

DEERFIELD, Ill., and OSAKA, Japan, Feb. 13 /PRNewswire/ -- Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals North America, Inc., announced today that the United States Food and Drug Administration (FDA) has approved ULORIC(R) (febuxostat) 40 mg and 80 mg for the chronic management of hyperuricemia in patients with gout. This once-daily, oral medication is the first new treatment option in more than 40 years for the more than five million patients who have hyperuricemia associated with gout. ULORIC was discovered by Teijin Pharma Limited (Teijin Pharma) of Tokyo and licensed to Takeda for the U.S. market.

"The approval of ULORIC offers clinicians and their patients who have hyperuricemia associated with gout a new treatment option that helps prevent uric acid production," said Nancy Joseph-Ridge, M.D., president, Takeda Global Research & Development Center, Inc., U.S. "In the years that we've dedicated to studying patients who have gout, I know that many patients go to their doctor during a flare not understanding that gout is a chronic disease that needs to be managed on a long-term, daily basis."

Experts recognize that a goal in the treatment of chronic gout is the reduction and maintenance of serum uric acid levels of less than 6 mg/dL. ULORIC, a xanthine oxidase inhibitor, effectively lowers levels of serum uric acid in patients with hyperuricemia associated with gout. It was studied and evaluated in multiple clinical trials involving more than 4,000 subjects, in some for up to five years.

The largest, pivotal, phase 3 clinical trial, CONFIRMS, demonstrated that ULORIC 80 mg was superior to ULORIC 40 mg and allopurinol 300/200 mg (67 percent, 45 percent and 42 percent, respectively) at achieving the primary end point of serum uric acid
'/>"/>

SOURCE Takeda Pharmaceutical Company Limited
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. FDA Approves Clinical Studies of a Novel Anti-Cancer Drug Developed by Italian Researchers
2. FDA Approves KAPIDEX(TM) (Dexlansoprazole) delayed release capsules for the Treatment of GERD
3. Bion Announces PENNVEST Board Approves $7.8 Million Financing for Kreider Farms Dairy Project
4. Monsanto Board Approves 10 Percent Dividend Increase
5. FDA Approves Most Comprehensive System to Test Donated Blood for HIV, Hepatitis B & Hepatitis C
6. MultiVu Video Feed: U.S Food and Drug Administration (Fda) Approves Latisse(TM) --
7. FDA Approves Boston Scientifics Express(R) SD Renal Stent System
8. AUDIO from Medialink and GlaxoSmithKline: FDA Approves Boostrix for Adults
9. FDA Approves Boston Scientifics Apex(TM) PTCA Dilatation Catheter
10. FDA Approves Ranexa(R) for First Line Anti Anginal Use and Adds New Claims for Reduction of Ventricular Arrhythmias, Bradycardia, New Atrial Fibrillation and HbA1c
11. FDA Approves Additional Indication for Norditropin(R) for Small for Gestational Age (SGA) in Children
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... Quincy Bioscience, a leading research company ... proteins to support healthy living, is pleased to ... apoaequorin in Food and Chemical Toxicology ... Industrial Biological Research Association. , The objective ... effects, if any, of apoaequorin, in rats following ...
(Date:5/23/2013)...  BioScrip, Inc. (NASDAQ: BIOS ) today ... 2013 Global Healthcare Conference to be held June 3-6, ... Richard Smith , President and Chief ... Chief Financial Officer, will present on Monday, June 3, ... About BioScrip BioScrip, Inc. provides comprehensive infusion ...
(Date:5/23/2013)... 2013 PuraMed BioScience ® , Inc., ... over-the-counter (OTC) medicinal and healthcare products, announced that ... company based on low market capitalization valuation. ... Natural Product to Treat Migraine Headaches , ... Competitor , Currently Available Nationwide at Walgreen,s ...
(Date:5/23/2013)... May 23, 2013 VG Energy, an ... with DAK Renewable Research to conduct field trials ... VG Energy is a majority owned subsidiary of ... VG Energy,s exclusively licensed compound LipidMax selectively ... yield in plants, possessing a wide variety of ...
Breaking Biology Technology:Safety Assessment Study of Apoaequorin Published in Food and Chemical Toxicology 2PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 2PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 3VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 2VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 3
... - OncoGenex Technologies Inc. and Isis,Pharmaceuticals, Inc. (NASDAQ: ... amended their agreement and OncoGenex has elected to ... amended agreement,OncoGenex is solely responsible for all future ... Isis will no longer be,responsible for funding 35% ...
... XI,AN, China, July 3 /Xinhua-PRNewswire-FirstCall/ -- Huifeng,Bio-Pharmaceutical ... leading,developer and producer of plant extracts and ... and food production in China,announced today that ... via,Standard & Poor,s Market Access Program, an ...
... July 3 Nabriva Therapeutics, a,specialist in antibiotics ... as Chief Executive Officer of the Company., ... years of industry,experience serving most recently as Vice ... oncology business unit at Novartis. In this,position he ...
Cached Biology Technology:OncoGenex increases economic interest in lead cancer drug OGX-011 2OncoGenex increases economic interest in lead cancer drug OGX-011 3OncoGenex increases economic interest in lead cancer drug OGX-011 4Huifeng Bio-Pharmaceutical (HFGB) Information to Be Available Through Standard & Poor's Market Access Program 2Nabriva Therapeutics Announces Appointment of New CEO 2
(Date:5/23/2013)... museums of the world are billions of animal and ... mushrooms and grasses, all stacked, stored and preserved in ... collections could be critical to understanding how the Earth,s ... human footprint if only the information were easily ... with the help of a team from the University ...
(Date:5/23/2013)... reveal the interplay of brain chemicals which help us ... and BBSRC. , By changing the way neurons ... While these changes can affect the strength of a ... that response. , Lead author Alex Thiele, ... others, you can make yourself better heard by speaking ...
(Date:5/22/2013)... 22, 2013 U.S. Forest Service scientists are part ... funding from the TKF Foundation, will examine how collaborative ... individuals recover from tragedy. , The TKF Foundation announced ... projects selected for grant funding. In addition to research ... in recovery and resiliency, the 3-year, $585,000 grant will ...
Breaking Biology News(10 mins):CU-Boulder helps tap crowds to digitize museum records of bugs and plants 2CU-Boulder helps tap crowds to digitize museum records of bugs and plants 3CU-Boulder helps tap crowds to digitize museum records of bugs and plants 4'Landscapes of Resilience' to study how people use nature as a source of recovery 2
... from oil palm plantations has calculated a more than ... than previously thought and warned that the demand ... The study from the University of Leicester was conducted ... think tank that wished to assess the greenhouse gas ...
... the number of burgers served has eclipsed the billion ... Genome Institute (JGI) will now serve up trillions of ... to feed the data-hungry worldwide research community. ... researchers to submit proposals for projects that advance capabilities ...
... share the most up-to-date news on the determinants of human ... current topics at The Gerontological Society of America ,s ... the largest interdisciplinary conference in the field of aging ... GSA extends complimentary registration to working representatives of the ...
Cached Biology News:New study suggests EU biofuels are as carbon intensive as petrol 2New study suggests EU biofuels are as carbon intensive as petrol 3New study suggests EU biofuels are as carbon intensive as petrol 4Trillions served: Massive, complex projects for DOE JGI 2012 Community Sequencing Program 2Trillions served: Massive, complex projects for DOE JGI 2012 Community Sequencing Program 3Trillions served: Massive, complex projects for DOE JGI 2012 Community Sequencing Program 4Trillions served: Massive, complex projects for DOE JGI 2012 Community Sequencing Program 5Register now! Boston meeting will showcase latest aging discoveries 2Register now! Boston meeting will showcase latest aging discoveries 3
... Mouse Antibody to Human Cytokeratin TYPE ... Basic (Type II) keratins. Including epidermal cell ... at 58kD, 65kD and 67kD. Broad keratin ... oesophagus and cornea. Immunogen: ...
BD BioCoat Fibronectin 150 mm Culture Dishes...
... a new product number, created to easily ... availability yet, please order under the old ... for assistance. ID clarifier: tissue-culture ... 500 cm 2 D H ...
... maximum packaging efficiencies of cDNA and genomic DNA ... a test insert with Novagen's l vector arms, ... 10^8 pfu/g ligated l control DNA) are typically ... use; simply add up to 5 g of ...
Biology Products: